Alzheimer’s disease is a devastating neurodegenerative disorder that affects millions worldwide, progressively impairing memory, cognitive function, and independence. Despite extensive research, current Alzheimer’s disease drugs provide only limited relief, and there remains no cure. With the number of cases projected to rise sharply in the coming decades, there is an urgent need for innovative treatments that go beyond existing therapies. As a result, the Alzheimer’s disease development landscape is expanding, with pharmaceutical companies investing heavily in novel approaches to slow or prevent disease progression.
Among the most promising developments in the Alz...
